Bipolar Disorder

Top Story

Prescription of second-generation, lower metabolic risk antipsychotics increases

May 21, 2017

SAN DIEGO — Findings presented here indicated that prescription of second-generation antipsychotics with lower metabolic risk have increased from 2006 to 2011, particularly for individuals with several metabolic disorders, but not those with cardiovascular disease.

“We know that patients with severe mental illness have a higher mortality rate than those without, estimates are between 13 and 30 years shorter life expectancy. That mortality gap has been widening in recent years,” Alisa Busch, MD, of McLean Hospital, said during a presentation. “Much of this excess mortality is due to medical comorbidity. We’ve known for a while now that second-generation antipsychotics can increase the risk for metabolic syndrome, which is a combination of different medical conditions —hypertension, hypercholesterolemia, diabetes and obesity — which in turn lead to increased risk for cardiovascular disease.”

Meeting NewsVideo

VIDEO: Genetic predictors of tardive dyskinesia

May 20, 2017
SAN DIEGO — In this video, James L. Kennedy, MD, of the Centre for Addiction and Mental Health, Toronto, discusses the use of genetic factors to predict risk for
FDA News

FDA approves generic Seroquel XR tablets

May 18, 2017
Pharmadax Inc. recently announced that the FDA approved a generic version of Seroquel XR tablets for schizophrenia and specific symptoms in bipolar disorder and…
In the Journals

Ketamine ineffective for adverse cognitive effects of ECT

April 19, 2017
Ketamine had no added benefit on neuropsychological and clinical outcomes in depression when added to electroconvulsive therapy, according to recent findings…
CME

Neurobiological Clues of Risk for Bipolar Disorder Development

Psychiatric Annals, October 2014, Volume 44 Issue 10
Bipolar disorder (BD) is a common, serious, and chronic disorder that leads to high morbidity and mortality in youth…
More »
CNE

Journal of Psychosocial Nursing and Mental Health Services January 2017 CNE Activity

This activity is co-provided by Villanova University College of Nursing and SLACK Incorporated.

Topics include telephone intervention for medication adherence in outpatients with schizophrenia spectrum disorders…
More »
Featured
American Psychiatric Association Annual Meeting

American Psychiatric Association Annual Meeting

Video
Meeting News

VIDEO: Genetic predictors of tardive dyskinesia

May 20, 2017
More »
Meeting News

Prescription of second-generation, lower metabolic risk antipsychotics increases

May 21, 2017
SAN DIEGO — Findings presented here indicated that prescription of second-generation antipsychotics with lower metabolic risk have increased…

Meeting NewsVideo

VIDEO: Genetic predictors of tardive dyskinesia

May 20, 2017
SAN DIEGO — In this video, James L. Kennedy, MD, of the Centre for Addiction and Mental Health, Toronto, discusses the use of genetic factors

FDA News

FDA approves generic Seroquel XR tablets

May 18, 2017
Pharmadax Inc. recently announced that the FDA approved a generic version of Seroquel XR tablets for schizophrenia and specific symptoms in bipolar…

In the Journals

Ketamine ineffective for adverse cognitive effects of ECT

April 19, 2017
Ketamine had no added benefit on neuropsychological and clinical outcomes in depression when added to electroconvulsive therapy, according to recent…

FDA News

FDA approves Ingrezza for tardive dyskinesia

April 12, 2017
The FDA recently approved Ingrezza capsules for treatment of tardive dyskinesia in adults. “Tardive dyskinesia can be disabling and can…

Latuda effective for bipolar I depression in children, adolescents

March 9, 2017
Sunovion recently announced positive phase 3 study findings for Latuda for bipolar I disorder depression in children aged 10 to 17 years…

In the Journals

Researchers offer consensus on ketamine for mood disorders

March 6, 2017
A recent consensus statement in JAMA Psychiatry reviewed available research on the use of ketamine for psychiatric indications and provided…

Top bipolar disorder research for psychiatrists

February 24, 2017
In the past year, 2.6% of U.S. adults reported bipolar disorder, according to the NIMH. Of these, 82.9% were severe cases.

FDA News

FDA orders drug, dietary supplement maker to immediately cease operations

February 23, 2017
United States District Judge Robert G. James for the District Court for the Western District of Louisiana issued a consent decree of permanent…

Feature Article

Mitochondrial Dysfunction and New Therapeutic Targets in Bipolar Affective Disorder

Psychiatric Annals, February 2017, Volume 47 Issue 2
Bipolar affective disorder (BAD) is a complex illness encompassing varying degrees of fluctuating disturbances of emotions, behavior, thought…

More Headlines »
Advertisement
Advertisement